282 related articles for article (PubMed ID: 37391845)
1. Fe
Xiao Y; Xu Z; Cheng Y; Huang R; Xie Y; Tsai HI; Zha H; Xi L; Wang K; Cheng X; Gao Y; Zhang C; Cheng F; Chen H
Biomater Res; 2023 Jul; 27(1):63. PubMed ID: 37391845
[TBL] [Abstract][Full Text] [Related]
2. Co-Administration of iRGD with Sorafenib-Loaded Iron-Based Metal-Organic Framework as a Targeted Ferroptosis Agent for Liver Cancer Therapy.
Liu X; Zhu X; Qi X; Meng X; Xu K
Int J Nanomedicine; 2021; 16():1037-1050. PubMed ID: 33603367
[TBL] [Abstract][Full Text] [Related]
3. Loss of LncRNA DUXAP8 synergistically enhanced sorafenib induced ferroptosis in hepatocellular carcinoma via SLC7A11 de-palmitoylation.
Shi Z; Li Z; Jin B; Ye W; Wang L; Zhang S; Zheng J; Lin Z; Chen B; Liu F; Zhang B; Ding X; Yang Z; Shan Y; Yu Z; Wang Y; Chen J; Chen Q; Roberts LR; Chen G
Clin Transl Med; 2023 Jun; 13(6):e1300. PubMed ID: 37337470
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA CASC11 suppresses sorafenib-triggered ferroptosis via stabilizing SLC7A11 mRNA in hepatocellular carcinoma cells.
Chen F; Wang L
Discov Oncol; 2023 Aug; 14(1):145. PubMed ID: 37552314
[TBL] [Abstract][Full Text] [Related]
5. Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ferroptosis.
Li Y; Yang W; Zheng Y; Dai W; Ji J; Wu L; Cheng Z; Zhang J; Li J; Xu X; Wu J; Yang M; Feng J; Guo C
J Exp Clin Cancer Res; 2023 Jan; 42(1):6. PubMed ID: 36604718
[TBL] [Abstract][Full Text] [Related]
6. SHP-1/STAT3-Signaling-Axis-Regulated Coupling between BECN1 and SLC7A11 Contributes to Sorafenib-Induced Ferroptosis in Hepatocellular Carcinoma.
Huang CY; Chen LJ; Chen G; Chao TI; Wang CY
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232407
[TBL] [Abstract][Full Text] [Related]
7. Iron chelator deferasirox inhibits NF-κB activity in hepatoma cells and changes sorafenib-induced programmed cell deaths.
Jomen W; Ohtake T; Akita T; Suto D; Yagi H; Osawa Y; Kohgo Y
Biomed Pharmacother; 2022 Sep; 153():113363. PubMed ID: 35834989
[TBL] [Abstract][Full Text] [Related]
8. ATF4 protects against sorafenib-induced cardiotoxicity by suppressing ferroptosis.
Jiang H; Wang C; Zhang A; Li Y; Li J; Li Z; Yang X; Hou Y
Biomed Pharmacother; 2022 Sep; 153():113280. PubMed ID: 35724508
[TBL] [Abstract][Full Text] [Related]
9. COMMD10 inhibits HIF1α/CP loop to enhance ferroptosis and radiosensitivity by disrupting Cu-Fe balance in hepatocellular carcinoma.
Yang M; Wu X; Hu J; Wang Y; Wang Y; Zhang L; Huang W; Wang X; Li N; Liao L; Chen M; Xiao N; Dai Y; Liang H; Huang W; Yuan L; Pan H; Li L; Chen L; Liu L; Liang L; Guan J
J Hepatol; 2022 May; 76(5):1138-1150. PubMed ID: 35101526
[TBL] [Abstract][Full Text] [Related]
10. Artesunate synergistically promotes sorafenib‑induced apoptosis and ferroptosis in non‑Hodgkin lymphoma cells through inhibition of the STAT3 pathway.
Chen Y; Tao H; Wang F; Wu P; Gao J; Zhang X; He Z; Zhou Z; Jia Y
Oncol Rep; 2023 Jul; 50(1):. PubMed ID: 37326033
[TBL] [Abstract][Full Text] [Related]
11. SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma.
Chen Q; Zheng W; Guan J; Liu H; Dan Y; Zhu L; Song Y; Zhou Y; Zhao X; Zhang Y; Bai Y; Pan Y; Zhang J; Shao C
Cell Death Differ; 2023 Jan; 30(1):137-151. PubMed ID: 35995846
[TBL] [Abstract][Full Text] [Related]
12. NIR-Triggered and ROS-Boosted Nanoplatform for Enhanced Chemo/PDT/PTT Synergistic Therapy of Sorafenib in Hepatocellular Carcinoma.
Wang C; Cheng X; Peng H; Zhang Y
Nanoscale Res Lett; 2022 Sep; 17(1):92. PubMed ID: 36125619
[TBL] [Abstract][Full Text] [Related]
13. LINC00942 inhibits ferroptosis and induces the immunosuppression of regulatory T cells by recruiting IGF2BP3/SLC7A11 in hepatocellular carcinoma.
Jin D; Hui Y; Liu D; Li N; Leng J; Wang G; Wang Q; Lu Z
Funct Integr Genomics; 2024 Feb; 24(1):29. PubMed ID: 38353724
[TBL] [Abstract][Full Text] [Related]
14. ABCC5 facilitates the acquired resistance of sorafenib through the inhibition of SLC7A11-induced ferroptosis in hepatocellular carcinoma.
Huang W; Chen K; Lu Y; Zhang D; Cheng Y; Li L; Huang W; He G; Liao H; Cai L; Tang Y; Zhao L; Pan M
Neoplasia; 2021 Dec; 23(12):1227-1239. PubMed ID: 34768109
[TBL] [Abstract][Full Text] [Related]
15. IGF2BP3-NRF2 axis regulates ferroptosis in hepatocellular carcinoma.
Lu Z; Yang H; Shao Y; Sun W; Jiang Y; Li J
Biochem Biophys Res Commun; 2022 Oct; 627():103-110. PubMed ID: 36030651
[TBL] [Abstract][Full Text] [Related]
16. Butyrate Modification Promotes Intestinal Absorption and Hepatic Cancer Cells Targeting of Ferroptosis Inducer Loaded Nanoparticle for Enhanced Hepatocellular Carcinoma Therapy.
Yu Y; Shen X; Xiao X; Li L; Huang Y
Small; 2023 Sep; 19(36):e2301149. PubMed ID: 37165608
[TBL] [Abstract][Full Text] [Related]
17. TEA Domain Transcription Factor 1 Inhibits Ferroptosis and Sorafenib Sensitivity of Hepatocellular Carcinoma Cells.
Li H; Lan H; Zhang M; Zhao F; An N; Yi C
Dig Dis Sci; 2023 Jul; 68(7):3070-3082. PubMed ID: 36680650
[TBL] [Abstract][Full Text] [Related]
18. Tumor-associated macrophages promote resistance of hepatocellular carcinoma cells against sorafenib by activating CXCR2 signaling.
Wang HC; Haung LY; Wang CJ; Chao YJ; Hou YC; Yen CJ; Shan YS
J Biomed Sci; 2022 Nov; 29(1):99. PubMed ID: 36411463
[TBL] [Abstract][Full Text] [Related]
19. E3 ubiquitin ligase CHIP interacts with transferrin receptor 1 for degradation and promotes cell proliferation through inhibiting ferroptosis in hepatocellular carcinoma.
Shao M; Qi K; Wang L; Yu X; Zhang Q; Yu L; Wang L; Yang C; Fan L
Cell Signal; 2024 Jun; 118():111148. PubMed ID: 38521179
[TBL] [Abstract][Full Text] [Related]
20. SLC27A5 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by downregulating glutathione reductase.
Xu FL; Wu XH; Chen C; Wang K; Huang LY; Xia J; Liu Y; Shan XF; Tang N
Cell Death Dis; 2023 Jan; 14(1):22. PubMed ID: 36635256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
